Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Novel Approach to Type 3 Diabetes Mechanism: The Interplay Between Noncoding Rnas and Insulin Signaling Pathway in Alzheimer's Disease Publisher Pubmed



Moayedi K1 ; Orandi S1 ; Ebrahimi R1, 2 ; Tanhapour M1 ; Moradi M3 ; Abbastabar M4 ; Golestani A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Clinical Biochemistry, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Students' Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Pediatric Infectious Diseases Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran
  4. 4. Department of Clinical Biochemistry, School of Medicine, Babol University of Medical Sciences, Babol, Iran

Source: Journal of Cellular Physiology Published:2022


Abstract

Today, growing evidence indicates that patients with type 2 diabetes (T2D) are at a higher risk of developing Alzheimer's disease (AD). Indeed, AD as one of the main causes of dementia in people aged more than 65 years can be aggravated by insulin resistance (IR) and other metabolic risk factors related to T2D which are also linked to the function of the brain. Remarkably, a new term called “type 3 diabetes” has been suggested for those people who are diagnosed with AD while also showing the symptoms of IR and T2D. In this regard, the role of genetic and epigenetic changes associated with AD has been confirmed by many studies. On the other hand, it should be noted that the insulin signaling pathway is highly regulated by various mechanisms, including epigenetic factors. Among these, the role of noncoding RNAs (ncRNAs), including microRNAs and long noncoding RNAs has been comprehensively studied with respect to the pathology of AD and the most well-known underlying mechanisms. Nevertheless, the number of studies exploring the association between ncRNAs and the downstream targets of the insulin signaling pathway in the development of AD has notably increased in recent years. With this in view, the present study aimed to review the interplay between different ncRNAs and the insulin signaling pathway targets in the pathogenesis of AD to find a new approach in the field of combining biomarkers or therapeutic targets for this disease. © 2022 Wiley Periodicals LLC.
Other Related Docs
17. The Role of Glycogen Synthase Kinase 3 Beta in Multiple Sclerosis, Biomedicine and Pharmacotherapy (2020)
24. Role of Non-Coding Rnas in Neuroblastoma, Cancer Gene Therapy (2023)